I know, international collaboration is not really "in" at the moment (and potentially declining).
So, here a #ShoutOut to #Eduroam! 
It made #SPRKrakow2025 just so much easier!
#sprkrakow2025
0 posts0 participants0 posts today
The Outstanding Early Career Achievement Award going to Clara Paz was excellent news at #SPRKrakow2025, very well-deserved! 
https://www.linkedin.com/posts/udla-investiga_internacional-despiertatupasiaejn-udlainvestiga-activity-7343749055069519874-4mAM/
www.linkedin.com🌍 Premio internacional para investigación UDLA en salud mental | Investigación y Vinculación UDLA🌍 Premio internacional para investigación UDLA en salud mental
Con orgullo compartimos que hoy, nuestra investigadora Clara Paz, jefa del grupo Bienestar, Salud y Sociedad, ha sido reconocida con el Outstanding Early Career Achievement Award por la Society for Psychotherapy Research (SPR), en el marco de su reunión anual realizada en Cracovia, Polonia.
Este reconocimiento #internacional destaca la relevancia y proyección de su trayectoria científica en el campo de la psicoterapia, así como su contribución al desarrollo de una salud mental basada en evidencia y con enfoque social.
La Dra. Paz se convierte en un referente regional en investigación clínica, y este logro posiciona a la Universidad de Las Américas (EC) como un actor clave en la generación de conocimiento con impacto humano.
#DespiertaTuPasión #UDLAinvestiga
That's what #SPRKrakow2025 is also good for:
Catching up with your #TShirtBuddy!
Great to see you @a_page !
The presentation by @kopf-beck.bsky.social provides makes connections between the results of the OPTIMA trial
https://pmc.ncbi.nlm.nih.gov/articles/PMC10880804/
(schema therapy in psychiatric care program showed #noninferiority compared to CBT)
https://onlinelibrary.wiley.com/doi/full/10.1155/2024/9191823
and comparative work on clinical interviews, questionnaires, and ecological momentary assessment outcomes within the trial
https://onlinelibrary.wiley.com/doi/full/10.1155/2024/9191823
PubMed Central (PMC)Effectiveness of Schema Therapy versus Cognitive Behavioral Therapy versus Supportive Therapy for Depression in Inpatient and Day Clinic Settings: A Randomized Clinical TrialSchema therapy (ST) reduces depressive symptoms, but clinical trials have not investigated its effectiveness for patients suffering from severe forms of depression and high rates of comorbidities. There is high demand for exploring and improving ...
Interesting to hear from Oded Bein about "Engage & Connect", a neuroscience-informed psychotherapy aimed to improve positive valence system functions and social reward responsivity, in late life depression
https://www.sciencedirect.com/science/article/pii/S0165178123004195
or in postpartum #depression:
https://osf.io/preprints/psyarxiv/n4p75_v1https://osf.io/preprints/psyarxiv/n4p75_v1
Did a morning run today at 05:45am and I can only ask:
Krakow? What's up with you?!
It was so busy, so many people around (and most of them not looking like nightowls 
). When does the usual day start here?!
In the panel "Promoting psychotherapy research in underrepresented contexts and populations: Challenges and opportunities" we hear from Latin American colleagues about the Consorcio Latinoamericano de Investigación en Psicoterapia
https://www.psychotherapyresearch.org/page/CLIP-About_engl
and a forthcoming book (c July 2025):
https://www.beck-shop.de/tomicic-duarte-soto-qualitative-research-clinical-psychology-psychotherapy-latin-america/product/38941308?srsltid=AfmBOookHw0TlRh9HQF0PpvxfkFQmaa2ZMRYOxuaUTXzw6NMDqk9SqN-
The journal Quality of Life Research has an open call for papers:
"Quality of life in people with mental disorders – beyond global scores"
Find the call text here:
https://link.springer.com/collections/cddjbdidbj
Linked editorial:
https://link.springer.com/article/10.1007/s11136-024-03844-4
Mentally preparing for being discussant for the panel "Making Routine Outcome Monitoring Very Brief" organised and moderated by Danilo Moggia.
We'll see psychometric data in different settings and groundwork for #itembanks and #crosswalks going well beyond single-item assessments.
https://mastodon.social/deck/@jrboehnke/114715647508184108
MastodonJan R. Boehnke (@jrboehnke@mastodon.social)Attached: 1 image
Looking forward to discussing work contributing to the European Psychotherapy Consortium (EPoC)!
EPoC homepage:
https://www.psychotherapyresearch.org/page/EPoC
Publication relating to these presentations:
https://www.psycharchives.org/en/item/43ccc929-5c44-40fe-b59a-9c2162fa3cd9
#SPRKrakow2025 #PsychotherapyResearch #Feedback #ROM #HRQOL
I was very happy to support my esteemed colleagues Ueli Kramer & Giovanna Esposito editing the #PsychotherapyResearch #SpecialIssue
"Therapist responsiveness in psychotherapy"
The 6 papers were published
https://www.tandfonline.com/toc/tpsr20/35/1
and we have a structured discussion at #SPRKrakow2025 
In a week's time #SPRKrakow2025 will be over already.
I am grateful to my colleagues for joining me for the panel
"Measuring what matters: How do we know that we do?"
#PsychotherapyResearch #Measurement #HRQOL #CoreOutcomes #DundeeUni
@paperbag1
Discussant: Michael Barkham, University of Sheffield, UK
Talks:
Constructing a measurement ontology of depression and depression related constructs
Presenter: Gary Brown, Royal Holloway University of London, UK
Looking forward to discussing work contributing to the European Psychotherapy Consortium (EPoC)!
EPoC homepage:
https://www.psychotherapyresearch.org/page/EPoC
Publication relating to these presentations:
https://www.psycharchives.org/en/item/43ccc929-5c44-40fe-b59a-9c2162fa3cd9
Looking forward to discussing the contributions in this #MixedMethods panel.
To me the QuantQual distinction is a distraction and often hindering people from combining multiple data types with multiple analysis methods.
Very glad to support researchers chipping away at this!
Preparing our panel on measuring what matters, revisiting this gem:
https://academic.oup.com/schizophreniabulletin/article-abstract/39/1/226/1889747?login=false
In 10k trials on the Cochrane Schizophrenia Group’s Register, 2194 different scales were employed with every fifth trial introducing a new rating instrument.